Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed (DTaP vaccine, BK1301)

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed (DTaP vaccine, BK1301)
Treatment and conditionWhere it standsTrials
Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed (DTaP vaccine, BK1301) for diphtheriaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed (DTaP vaccine, BK1301) for tetanusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1